23 August 2017 - The agenda for the November 2017 PBAC meeting is now available.
The company applying for subsidy under the Pharmaceutical Benefits Scheme has already provided the PBAC with detailed clinical and economic data in support of the application. You are welcome to provide comments, for consideration by the PBAC, from a personal or group perspective on the impact of the condition addressed in the application.
A full analysis of the agenda will feature in future issue of MAESTrO Daily.